Terri B. Sebree
2021
In 2021, Terri B. Sebree earned a total compensation of $1.6M as President at Zynerba Pharmaceuticals, a 44% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $288,933 |
---|---|
Option Awards | $303,409 |
Salary | $464,409 |
Stock Awards | $537,000 |
Other | $10,685 |
Total | $1,604,436 |
Sebree received $537K in stock awards, accounting for 33% of the total pay in 2021.
Sebree also received $288.9K in non-equity incentive plan, $303.4K in option awards, $464.4K in salary and $10.7K in other compensation.
Rankings
In 2021, Terri B. Sebree's compensation ranked 6,962nd out of 12,415 executives tracked by ExecPay. In other words, Sebree earned more than 43.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,962 | 44th |
Manufacturing | 3,048 | 45th |
Chemicals And Allied Products | 1,351 | 43rd |
Drugs | 1,206 | 43rd |
Pharmaceutical Preparations | 878 | 43rd |
Sebree's colleagues
We found two more compensation records of executives who worked with Terri B. Sebree at Zynerba Pharmaceuticals in 2021.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019